Pharmaceutical Development and Clinical Pharmacokinetic Evaluation of Gastroretentive Floating Matrix Tablets of Levofloxacin
DOI:
https://doi.org/10.37285/ijpsn.2011.4.3.4Abstract
The most common approach for achieving sustained drug release is by the use of hydrophilic polymeric excipients directly compressed with active ingredients into tablets. Hydrophilic polymers swell in the presence of water to form hydrogel structures from which drugs are released by slow diffusion. The purpose of this study was to prepare a floating drug delivery system of levofloxacin, a fluoroquinolone antibiotic. Levofloxacin is highly soluble in acidic media and precipitates in alkaline media, thereby losing its solubility. We designed a gastroretentive system of levofloxacin to enhance bioavailability by retaining them in the acidic environment of the stomach. Tablets were prepared by the direct compression technique using polymers such as hydroxypropyl- methylcellulose (HPMC K4M, HPMC K15M, and HPMC K100M). Sodium bicarbonate was utilized as a gas-generating agent. Tables were evaluated for their physical characteristics such as hardness, thickness, friability, weight variation, drug content, swelling studies, and floating properties. Tablet formulations were evaluated by in vitro dissolution studies. Formulations showed a floating lag time of 30 seconds and a floating time above 12 hours. Among these formulations F3, F7 and F11 exhibited controlled and prolonged drug release profiles while floating over the dissolution medium. The best formulation (F3) was selected based on in vitro characteristics and further tested in healthy volunteers by radiographic studies of tablets by incorporating BaSO4. These clinical studies revealed that the tablets remained in the stomach for 240 ± 30 minutes in fasting human volunteers, indicating gastric retention of the system.
Downloads
Metrics
Keywords:
Levofloxacin, floating matrix tablets, gastric retention, radiographic studies
Downloads
Published
How to Cite
Issue
Section
References
Bandari S, Eaga CM, Thadishetty A and Rao YM (2010). Formulation and evaluation of multiple tablets as a biphasic gastro retentive floating drug delivery system for fenoverine. Acta Pharm 60: 89–97.
Bardonn PL, Faivre V, Pugh WJ, Piffaretti JC and Falson F (2006). Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J Control Rel 111:1-18.
Bomma R, Naidu RAS, Rao YM and Veerabrahma K (2009). Development and evaluation of gastro retentive norfloxacin floating tablets. Acta Pharm 59:211–221.
Brazel CS and Peppas NA (2000). Modeling of drug release from swellable polymers. Eur J Pharm Biopharm 49:47-58.
Chavanpatil M, Jain P, Chaudhari S, Shear R and Vavia P (2005). Development of sustained release gastro retentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int J Pharmaceutics 304: 178-184.
David G, Friedmann JC, Marmo E and Pierre R (1986). Pharmacodynamic profile of fenoverine, a novel modulator of smooth muscle motility. Acta Ther 12: 309–335.
Forman D, Webb P and Parsonnet J (1994). Helicobacter pylori and gastric cancer. Lancet 343:243-244.
Gandhi R, Kaul CL and Panchagnula R (1999). Extrusion and spheronization in the development of oral controlled release dosage forms. Pharm Sci Tech Today 2: 160–170.
Gohel MC, Panchal MK and Jogani VV (2000). Novel mathematical method for quantitative expression of deviation from the Higuchi model. AAPS Pharm Sci Tech 1:45-50.
Hamid AM, Harris MS, Jaweria Tand Rabia IY (2006). Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note. AAPS PharmSciTech 7: Article 78.
Higuchi T (1963). Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145-1148.
Hoffman A, Donbrow M, Gross ST, Benita S and Bahat R (1986). Fundamentals of release mechanism interpretation in multiparticulate systems: determination of substrate release from single microcapsules and relation between individual and ensemble release kinetics. Int J Pharm 29: 195–211.
Janardhan D, Sreekanth J, Bharat V and Subramaniyan PR (2009). Formulation and evaluation of gastro retentive drug delivery system for ofloxacin. Int J Pharma Sci Nanotech 2(1):189-198.
Klaussner EA, Lavy E, Friedman M and Hoffman A (2003). Expandable gastro retentive dosage forms. J Control Rel 90: 143–162.
Korsmeyer RW, Gurny R, Doelker E, Buri P and Peppas NA (1983). Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 15:25-35.
Lapidus H and Lordi NG (1966). Some factors affecting the release of a water soluble drug from a compressed hydrophilic matrix. J Pharm Sci 55:840-843.
Megraud F and Lamouliatte H (1992). Helicobacter pylori and duodenal ulcers. Dig Dis Sci 37:769-772.
Meka L, Kesavan B, Kalamata VN, Eaga CM, Bandari S, Vobalaboina V and Rao YM (2009). Design and evaluation of polymeric coated minitablets as multiple unit Gastro retentive floating drug delivery systems for furosemide. J Pharm Sci 98: 2122-2132.
Moes AJ (1993). Gastro retentive dosage forms. Crit Rev Ther Drug Carrier Syst 10: 143–195.
Okeri HA and Arhewoh IM (2008). Analytical profile of the fluoroquinolone antibacterials. African J Biotech 17(6): 670-680.
Park SHH and Park K (1998). Gastric retentive drug delivery systems. Crit. Rev. Ther. Drug Carrier Syst 15: 243–284.
Patel VF and Patel NM (2006). Intra Gastric Floating Drug Delivery System of Cefuroxime Axetil: In Vitro Evaluation. AAPS Pharma SciTech 7(1): E1-E7.
Rosa M, Zia H and Rhodes T (1994). Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 105:65-70.
Singh BN and Kim KH (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Rel 63: 235–259.
Warren JR, Marshall B (1983). Unified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 321:1273-1275.
